Developing an international corporate tax structure: the tale of a French biotech startup
by Peter Horn
International Journal of Management and Decision Making (IJMDM), Vol. 5, No. 4, 2004

Abstract: Argogen biotech SA was created in France in December 1999. During a ''strategy'' brainstorming session, the management team realised the need for international expansion. This report analysis the work performed by the firm's International Development Task Force. It discusses the circumstances surrounding the formation of the task force, critiques its work, examines the various alternatives presented to the firm, details the actual expansion of the firm into the USA; and, as a closing comment, suggests a ''model'' whereby companies considering international expansion can develop a personalised plan for minimising the group's total tax burden while still satisfying the firm's strategic objectives.

Online publication date: Mon, 08-Nov-2004

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Management and Decision Making (IJMDM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com